National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1256021

History of Changes from the VAERS Wayback Machine

First Appeared on 4/30/2021

VAERS ID: 1256021
VAERS Form:2
Age:38.0
Sex:Female
Location:Virginia
Vaccinated:2021-04-12
Onset:2021-04-19
Submitted:0000-00-00
Entered:2021-04-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 043A21A / 1 RA / IM

Administered by: Pharmacy      Purchased by: ??
Symptoms: Anaemia, Condition aggravated, Injection site erythema, Injection site rash, International normalised ratio normal, Nausea, Prothrombin time, Rash, Rash macular

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? Yes
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: AURYXIA 210MG TAB, 2 TABS BY MOUTH EVERY 12 HOURS WITH MEALS ONDANSETRON ODT 4MG, 2 TABS EVERY 12 HOURS AS NEEDED FOR NAUSEA NAPROXEN 225MG, 2 TABS PO DAILY AS NEEDED FOR HEADACHE *MULTIPLE OTHER MEDICATIONS INCLUDING HEAPRIN ADMINISTERED
Current Illness: CHRONIC KIDNEY DISEASE STAGE FIVE ON DIALYSIS
Preexisting Conditions: CKD STAGE 5
Allergies: ROCEPHIN IV DYE
Diagnostic Lab Data: PT/INR AND CBC WITH NORMAL RESULTS EXCEPT SLIGHT ANEMIA WHICH IS NORMAL FOR PATIENT
CDC 'Split Type':

Write-up: PATIENT WOKE UP MORNING OF 04/19/21 COVERED IN TINY RED DOTS HEAD TO TOE WITH LARGEST BEING AT INJECTION SITE. THE PATIENT HAS ALSO SUFFERED FROM WORSENING NAUSEA SINCE VACCINE.


Changed on 5/7/2021

VAERS ID: 1256021 Before After
VAERS Form:2
Age:38.0
Sex:Female
Location:Virginia
Vaccinated:2021-04-12
Onset:2021-04-19
Submitted:0000-00-00
Entered:2021-04-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 043A21A / 1 RA / IM

Administered by: Pharmacy      Purchased by: ??
Symptoms: Anaemia, Condition aggravated, Injection site erythema, Injection site rash, International normalised ratio normal, Nausea, Prothrombin time, Rash, Rash macular

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? Yes
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: AURYXIA 210MG TAB, 2 TABS BY MOUTH EVERY 12 HOURS WITH MEALS ONDANSETRON ODT 4MG, 2 TABS EVERY 12 HOURS AS NEEDED FOR NAUSEA NAPROXEN 225MG, 2 TABS PO DAILY AS NEEDED FOR HEADACHE *MULTIPLE OTHER MEDICATIONS INCLUDING HEAPRIN ADMINISTERED
Current Illness: CHRONIC KIDNEY DISEASE STAGE FIVE ON DIALYSIS
Preexisting Conditions: CKD STAGE 5
Allergies: ROCEPHIN IV DYE DYE
Diagnostic Lab Data: PT/INR AND CBC WITH NORMAL RESULTS EXCEPT SLIGHT ANEMIA WHICH IS NORMAL FOR PATIENT
CDC 'Split Type':

Write-up: PATIENT WOKE UP MORNING OF 04/19/21 COVERED IN TINY RED DOTS HEAD TO TOE WITH LARGEST BEING AT INJECTION SITE. THE PATIENT HAS ALSO SUFFERED FROM WORSENING NAUSEA SINCE VACCINE.


Changed on 5/14/2021

VAERS ID: 1256021 Before After
VAERS Form:2
Age:38.0
Sex:Female
Location:Virginia
Vaccinated:2021-04-12
Onset:2021-04-19
Submitted:0000-00-00
Entered:2021-04-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 043A21A / 1 RA / IM

Administered by: Pharmacy      Purchased by: ??
Symptoms: Anaemia, Condition aggravated, Injection site erythema, Injection site rash, International normalised ratio normal, Nausea, Prothrombin time, Rash, Rash macular

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? Yes
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: AURYXIA 210MG TAB, 2 TABS BY MOUTH EVERY 12 HOURS WITH MEALS ONDANSETRON ODT 4MG, 2 TABS EVERY 12 HOURS AS NEEDED FOR NAUSEA NAPROXEN 225MG, 2 TABS PO DAILY AS NEEDED FOR HEADACHE *MULTIPLE OTHER MEDICATIONS INCLUDING HEAPRIN ADMINISTERED
Current Illness: CHRONIC KIDNEY DISEASE STAGE FIVE ON DIALYSIS
Preexisting Conditions: CKD STAGE 5
Allergies: ROCEPHIN IV DYE DYE
Diagnostic Lab Data: PT/INR AND CBC WITH NORMAL RESULTS EXCEPT SLIGHT ANEMIA WHICH IS NORMAL FOR PATIENT
CDC 'Split Type':

Write-up: PATIENT WOKE UP MORNING OF 04/19/21 COVERED IN TINY RED DOTS HEAD TO TOE WITH LARGEST BEING AT INJECTION SITE. THE PATIENT HAS ALSO SUFFERED FROM WORSENING NAUSEA SINCE VACCINE.

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1256021&WAYBACKHISTORY=ON


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166